The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Financial Crossroads | Cigna faces challenges with increased high-cost claims, adjusting EPS guidance downward, while core businesses show resilience in a complex healthcare landscape |
Strategic Positioning | Explore Cigna's strong market presence in PBM and specialty drugs, and its focus on biosimilars as key growth drivers amidst industry evolution |
Merger Speculation | Delve into the potential Cigna-Humana merger, offering strategic advantages but presenting risks of shareholder approval and prolonged uncertainty |
Future Outlook | Analyst price targets range from $339 to $420, reflecting varied perspectives on Cigna's ability to navigate industry trends and capitalize on opportunities |
Metrics to compare | CI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCIPeersSector | |
---|---|---|---|---|
P/E Ratio | 25.0x | 28.4x | −0.5x | |
PEG Ratio | −0.83 | −2.07 | 0.00 | |
Price/Book | 2.1x | 4.5x | 2.6x | |
Price / LTM Sales | 0.3x | 1.6x | 3.0x | |
Upside (Analyst Target) | 12.4% | 11.9% | 54.7% | |
Fair Value Upside | Unlock | 2.9% | 9.3% | Unlock |